Predicting mortality and short-term outcomes of continuous kidney replacement therapies in neonates and infants

Anna Deja1,2, Kamil Deja3,4, Andrea Cappoli5

  • 1Department of Pediatrics and Nephrology, Medical University of Warsaw, Warsaw, Poland.

Insights

Artificial intelligence models identified key factors for mortality and kidney issues in infants and neonates undergoing continuous kidney replacement therapy (CKRT). Lower urine output and longer time to CKRT initiation increased mortality risk.

Area of Science:

  • Pediatric Nephrology
  • Critical Care Medicine
  • Artificial Intelligence in Healthcare

Background:

  • Continuous kidney replacement therapy (CKRT) is crucial for critically ill neonates and infants with acute kidney injury (AKI).
  • Identifying factors influencing mortality and adverse kidney outcomes in this vulnerable population is essential.

Purpose of the Study:

  • To apply Artificial Intelligence (AI), specifically XGBoost models, to identify clinical factors associated with short-term outcomes in neonates and infants undergoing CKRT.
  • To predict mortality and proteinuria at hospital discharge in this patient group.

Main Methods:

  • Utilized data from the EurAKId registry (NCT02960867) including neonates and infants treated with CKRT.
  • Employed AI XGBoost models to analyze clinical characteristics, anthropometric features, and CKRT technical settings.
  • Identified key predictors for mortality and proteinuria at discharge.

Main Results:

  • The study included 95 patients; overall mortality was 47.3%.
  • AI models indicated lower urine output, greater serum creatinine rise, delayed CKRT initiation, and lower blood pressure as mortality risk factors.
  • Higher admission/CKRT start serum creatinine and primary kidney disease predicted proteinuria at discharge.

Conclusions:

  • XGBoost models effectively identify short-term outcome predictors in pediatric CKRT patients.
  • Early indicators of AKI severity and treatment delay are critical for mortality risk in neonates and infants.
  • Primary kidney disease and biochemical markers are significant predictors of proteinuria.
Abstract

Related Concept Videos

Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
141
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
81
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
60
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
44
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
91
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
75